-
January 27, 2018PREVIEW
FDA approved lutetium Lu 177 dotatate for treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs...
-
December 28, 2017PREVIEW
...
-
December 28, 2017PREVIEW
FDA has granted marketing approval for macimorelin, an orally...
-
December 24, 2017PREVIEW
FDA approved angiotensin II injection for I.V. infusion under the trade name Giapreza to increase blood...
-
December 22, 2017PREVIEW
FDA has approved voretigene neparvovec-rzyl, a one-time gene therapy product indicated for the treatment of patients with confirmed biallelic RPE65 ...
Pages
